P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844348.09845.a2 |
| _version_ | 1827336865966981120 |
|---|---|
| author | F. Ravandi E. Jabbour N. Jain T. Kadia B. Gautam M. Konopleva W. Wierda J. Burger G. Issa A. Maiti H. Balkin M. Kelly R. Garris P. Kebriaei A. Ferrajoli G. Garcia-Manero Y. Alvarado N. Short H. Kantarjian |
| author_facet | F. Ravandi E. Jabbour N. Jain T. Kadia B. Gautam M. Konopleva W. Wierda J. Burger G. Issa A. Maiti H. Balkin M. Kelly R. Garris P. Kebriaei A. Ferrajoli G. Garcia-Manero Y. Alvarado N. Short H. Kantarjian |
| author_sort | F. Ravandi |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:45Z |
| format | Article |
| id | doaj.art-9b6e0e3b37564792a4253a75c90d96f2 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:45Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-9b6e0e3b37564792a4253a75c90d96f22024-03-02T03:51:54ZengWileyHemaSphere2572-92412022-06-01626526610.1097/01.HS9.0000844348.09845.a2202206003-00265P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)F. Ravandi0E. Jabbour1N. Jain2T. Kadia3B. Gautam4M. Konopleva5W. Wierda6J. Burger7G. Issa8A. Maiti9H. Balkin10M. Kelly11R. Garris12P. Kebriaei13A. Ferrajoli14G. Garcia-Manero15Y. Alvarado16N. Short17H. Kantarjian181 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America1 The University of Texas - MD Anderson Cancer Center, HOUSTON, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000844348.09845.a2 |
| spellingShingle | F. Ravandi E. Jabbour N. Jain T. Kadia B. Gautam M. Konopleva W. Wierda J. Burger G. Issa A. Maiti H. Balkin M. Kelly R. Garris P. Kebriaei A. Ferrajoli G. Garcia-Manero Y. Alvarado N. Short H. Kantarjian P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL) HemaSphere |
| title | P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL) |
| title_full | P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL) |
| title_fullStr | P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL) |
| title_full_unstemmed | P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL) |
| title_short | P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL) |
| title_sort | p365 incorporation of nelarabine nel pegylated asparaginase peg and venetoclax ven in the frontline therapy of adult patients with t acute lymphoblastic leukemia t lymphoblastic lymphoma t all lbl |
| url | http://journals.lww.com/10.1097/01.HS9.0000844348.09845.a2 |
| work_keys_str_mv | AT fravandi p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT ejabbour p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT njain p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT tkadia p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT bgautam p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT mkonopleva p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT wwierda p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT jburger p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT gissa p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT amaiti p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT hbalkin p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT mkelly p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT rgarris p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT pkebriaei p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT aferrajoli p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT ggarciamanero p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT yalvarado p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT nshort p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl AT hkantarjian p365incorporationofnelarabinenelpegylatedasparaginasepegandvenetoclaxveninthefrontlinetherapyofadultpatientswithtacutelymphoblasticleukemiatlymphoblasticlymphomatalllbl |